NASDAQ
No price data available for this timeframe.
Foghorn Therapeutics Inc. (FHTX) has a price/fcf ratio of -3.95x as of Monday, May 25, 2026. This represents a 18.26% increase compared to its 12-month average of -4.83x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.